Anthropometrics and cancer prognosis: a multicenter cohort study
Yue Chen(First Affiliated Hospital Zhejiang University), Hanping Shi(Beijing Shijitan Hospital), Li Deng(Sichuan University), Hailun Xie(Guangxi Medical University), Heyang Zhang(Academy of Military Medical Sciences), Zhaoting Bu(Capital Medical University), Shubin Guo(Capital Medical University), Chenan Liu(Hunan University of Technology), Ying Liu(Shanghai First Maternity and Infant Hospital), Xiaoyue Liu(Zhejiang University), Xin Zheng(Capital Medical University), Shiqi Lin(Nanjing University of Information Science and Technology), Jinyu Shi(Capital Medical University), Zhenghui Huang(Beijing Chao-Yang Hospital, Capital Medical University)
Cited by 8
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2023|892
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|189
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
|Journal of Cachexia Sarcopenia and Muscle|2022|170